New Nordic Healthbrands AB (FRA:N9X) EBIT: €0.80 Mil (TTM As of Mar. 2026)


FRA:N9X New Nordic Healthbrands AB FRA:N9X
64 GF Score
Price €1.04
GF Value €1.72
! 4 Warning Signs
View Full Analysis

What is New Nordic Healthbrands AB EBIT?

New Nordic Healthbrands AB FRA:N9X -2.36% 64 EBIT is €0.80 Mil as of Mar. 2026. GuruFocus rates FRA:N9X with a GF Score™ of 64/100 and a GF Value™ of €1.72. The stock has 4 warning signs investors should review.

New Nordic Healthbrands AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €-0.14 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.80 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. New Nordic Healthbrands AB's annualized ROC % for the quarter that ended in Mar. 2026 was -3.03%. New Nordic Healthbrands AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -5.92%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. New Nordic Healthbrands AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 8.39%.


New Nordic Healthbrands AB  (FRA:N9X) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

New Nordic Healthbrands AB's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-0.56 * ( 1 - 0% )/( (13.426 + 23.497)/ 2 )
=-0.56/18.4615
=-3.03 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

New Nordic Healthbrands AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.56/( ( (0.372 + max(8.641, 0)) + (0.352 + max(9.54, 0)) )/ 2 )
=-0.56/( ( 9.013 + 9.892 )/ 2 )
=-0.56/9.4525
=-5.92 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.335 + 9.592 + 0.526) - (7.673 + 0 + 2.139)
=8.641

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9.465 + 10.747 + 0.715) - (0.238 + 0 + 11.149)
=9.54

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

New Nordic Healthbrands AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=0.798/9.512
=8.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


New Nordic Healthbrands AB EBIT Related Terms


New Nordic Healthbrands AB EBIT Historical Data

* Premium members only.

The historical data trend for New Nordic Healthbrands AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Nordic Healthbrands AB EBIT Chart

New Nordic Healthbrands AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.78 -0.33 -0.33 -0.35 1.35

New Nordic Healthbrands AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.34 0.25 0.35 -0.14

FRA:N9X vs KHC, GIS, JBS: EBIT Comparison

For the Packaged Foods subindustry, New Nordic Healthbrands AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Nordic Healthbrands AB EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where New Nordic Healthbrands AB's EV-to-EBIT falls into.


FRA:N9X
64GF Score
New Nordic Healthbrands AB FRA:N9X
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Nordic Healthbrands AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €0.80 Mil mean?
New Nordic Healthbrands AB (FRA:N9X) has a EBIT of €0.80 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on New Nordic Healthbrands AB.
Is New Nordic Healthbrands AB's EBIT too high?
New Nordic Healthbrands AB's current EBIT is €0.80 Mil. Overall, New Nordic Healthbrands AB has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's EBIT compare to KHC and GIS?
New Nordic Healthbrands AB's EBIT of €0.80 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on New Nordic Healthbrands AB. New Nordic Healthbrands AB's current EBIT is €0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current EBIT of €0.80 Mil. The stock's GF Value™ is €1.72, compared to a current price of €1.04 — trading 39.8% below its estimated fair value. The current EBIT is €0.80 Mil. New Nordic Healthbrands AB's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current EBIT is €0.80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?

Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued. The current stock price of €1.04 is trading 39.8% below its estimated GF Value™ of €1.72.

Key valuation signals for FRA:N9X:

  • EBIT: €0.80 Mil
  • GF Value™: €1.72 vs. price of €1.04 (39.8% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


New Nordic Healthbrands AB Business Description

Other Exchanges NNH:Sweden
Address Sodra Forstadsgatan 3, Malmo, SWE, 211 43
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
64GF Score

Get the complete analysis for FRA:N9X

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price
€1.72
GF Value